Published on:
Susan Haigney
Pharmaceutical Technology, Pharmaceutical Technology, March 2023, Volume 47, Issue 3
Pages: 16-19
The ability of artificial intelligence to process large amounts of diverse data cleanly creates more accurate reports for improved drug safety.
The World Health Organization defines pharmacovigilance as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine/vaccine related problem” (1). Drug safety includes quality control during the development and manufacture of a drug and monitoring the safety of the drug post-approval when it is in the market and being used by patients.